Partitioning and inactivation of viruses by the caprylic acid precipitation followed by a terminal pasteurization in the manufacturing process of horse immunoglobulins-Reference-Cited by-同舟云学术

Partitioning and inactivation of viruses by the caprylic acid precipitation followed by a terminal pasteurization in the manufacturing process of horse immunoglobulins

Published:2007-10 Issue:4 Volume:35 Page:335-341
ISSN:1045-1056
Container-title:Biologicals
language:en
Short-container-title:Biologicals

Author:

Mpandi M.,Schmutz P.,Legrand E.,Duc R.,Geinoz J.,Henzelin-Nkubana C.,Giorgia S.,Clerc O.,Genoud D.,Weber T.

Publisher

Elsevier BV

Subject

Pharmacology,General Immunology and Microbiology,Applied Microbiology and Biotechnology,General Medicine,Bioengineering,Biotechnology

Reference29 articles.

1. Buchacher A, Iberer G. Biotechnol J. Purification of intravenous immunoglobulin G from human plasma—aspects of yield and virus safety 2006 Feb;1(2):148–163.

2. Conseil de l'Europe, 67075;Pharmacopée Européenne, IV ème édition, DEQM,2002

3. Inactivation of lipid-enveloped viruses in labile blood derivates by unsaturated fatty acids;Lundblad;Vox Sang,1991

4. Review of the toxicologic properties of medium-chain triglycerides;Traul;Food Chem Toxicol,2000

5. The isolation of IgG from mammalian sera with the aid of caprylic acid;Steinbuch;Arch Biochem Biophys,1969

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Understanding virus retention mechanisms on protein a chromatography based on using different wash buffers – Evaluating the possibility for a generic wash buffer toolbox to improve virus clearance capacity;Biotechnology Notes;2024

2. Back to the Cradle of Cytotherapy: Integrating a Century of Clinical Research and Biotechnology-Based Manufacturing for Modern Tissue-Specific Cellular Treatments in Switzerland;Bioengineering;2021-12-17

3. Development and characterization of two equine formulations towards SARS-CoV-2 proteins for the potential treatment of COVID-19;Scientific Reports;2021-05-10

4. Development and pre-clinical characterization of two therapeutic equine formulations towards SARS-CoV-2 proteins for the potential treatment of COVID-19;2020-10-19

5. Current technology for the industrial manufacture of snake antivenoms;Toxicon;2018-09